SODIUM SULFACETAMIDE AND SULFUR avobenzone octinoxate octisalate

Land: Bandaríkin

Tungumál: enska

Heimild: NLM (National Library of Medicine)

Virkt innihaldsefni:

SULFACETAMIDE SODIUM (UNII: 4NRT660KJQ) (SULFACETAMIDE - UNII:4965G3J0F5)

Fáanlegur frá:

BioComp Pharma, Inc.

INN (Alþjóðlegt nafn):

SULFACETAMIDE SODIUM

Samsetning:

SULFACETAMIDE SODIUM 90 mg in 1 g

Gerð lyfseðils:

PRESCRIPTION DRUG

Leyfisstaða:

unapproved drug other

Vara einkenni

SODIUM SULFACETAMIDE AND SULFUR- SODIUM SULFACETAMIDE, SULFUR,
AVOBENZONE
OCTINOXATE, OCTISALATE
BIOCOMP PHARMA, INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
SODIUM SULFACETAMIDE 9% AND SULFUR 4.5% WASH KIT WITH SUNSCREEN
RX ONLY
DESCRIPTION:
Each mL of Sodium Sulfacetamide 9% and Sulfur 4.5% Wash contains 90 mg
of sodium sulfacetamide
and 45 mg of sulfur in a formulation of: aloe vera, butylated
hydroxytoluene, cetyl alcohol, disodium
EDTA, disodium oleamido MEA sulfosuccinate, fragrance, glyceryl
stearate (and) PEG-100 stearate,
green tea extract, magnesium aluminum silicate, methylparaben,
propylparaben, purified water, sodium
cocoyl isethionate, sodium methyl cocoyl taurate, sodium thiosulfate,
stearyl alcohol and xanthan gum.
Sodium sulfacetamide is a sulfonamide with antibacterial activity
while sulfur acts as a keratolytic
agent. Sodium sulfacetamide is C
H
N
NaO
S·H
O with molecular weight of 254.24. Chemically,
sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide,
monosodium salt, monohydrate. The
structural formula is:
INDICATIONS:
Sodium Sulfacetamide 9% and Sulfur 4.5% Wash is indicated in the
topical control of acne vulgaris,
acne rosacea and seborrheic dermatitis.
CONTRAINDICATIONS:
Sodium Sulfacetamide 9% and Sulfur 4.5% Wash is contraindicated for
use by patients having known
hypersensitivity to sulfonamides, sulfur, or any other component of
this preparation. This drug is not to
be used by patients with kidney disease.
CLINICAL PHARMACOLOGY:
The most widely accepted mechanism of action of sulfonamides is the
Woods-Fildes theory, which is
based on the fact that sulfonamides act as competitive antagonists to
para-aminobenzoic acid (PABA), an
essential component for bacterial growth. While absorption through
intact skin has not been determined,
sodium sulfacetamide is readily absorbed from the gastrointestinal
tract when taken orally